Vcanbio Cell & Gene Engineering Corp Ltd Total Liabilities

Latest as of March 2026: CN¥1.50 Billion CNY ≈ $219.17 Million USD

Vcanbio Cell & Gene Engineering Corp Ltd total liabilities. Based on the latest financial reports, Vcanbio Cell & Gene Engineering Corp Ltd (600645) has total liabilities worth CN¥1.50 Billion CNY (≈ $219.17 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Vcanbio Cell & Gene Engineering Corp Ltd (600645) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Vcanbio Cell & Gene Engineering Corp Ltd (1992–2025)

Total liabilities of Vcanbio Cell & Gene Engineering Corp Ltd from 1992 to 2025. This chart illustrates how Vcanbio Cell & Gene Engineering Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 600645 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Vcanbio Cell & Gene Engineering Corp Ltd Competitors by Total Liabilities

The table below lists competitors of Vcanbio Cell & Gene Engineering Corp Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Asuransi Jiwa Sinarmas Msig PT JK:LIFE	Indonesia	Rp6.71 Trillion
Shandong Sacred Sun Power Sources Co Ltd SHE:002580	China	CN¥1.62 Billion
Sarawak Oil Palms Bhd KLSE:5126	Malaysia	RM1.51 Billion
Zhejiang Shibao Co Ltd SHE:002703	China	CN¥1.74 Billion
NAVIGATOR HLDGS LTD F:1NV	Germany	€1.02 Billion
Supreme Electronics Co Ltd TW:8112	Taiwan	NT$64.28 Billion
PT Sarana Menara JK:TOWR	Indonesia	Rp57.73 Trillion
VIEL & Cie société anonyme PA:VIL	France	€2.21 Billion

Liability Composition Analysis (1992–2025)

This chart breaks down Vcanbio Cell & Gene Engineering Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Vcanbio Cell & Gene Engineering Corp Ltd balance sheet assets.

Liquidity & Leverage Metrics

Vcanbio Cell & Gene Engineering Corp Ltd Total Liabilities Ratios Explained

Vcanbio Cell & Gene Engineering Corp Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.40	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vcanbio Cell & Gene Engineering Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vcanbio Cell & Gene Engineering Corp Ltd (1992–2025)

The table below shows the annual total liabilities of Vcanbio Cell & Gene Engineering Corp Ltd from 1992 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.54 Billion ≈ $224.98 Million	-3.30%
2024-12-31	CN¥1.59 Billion ≈ $232.65 Million	-1.42%
2023-12-31	CN¥1.61 Billion ≈ $236.00 Million	-1.12%
2022-12-31	CN¥1.63 Billion ≈ $238.66 Million	+8.69%
2021-12-31	CN¥1.50 Billion ≈ $219.59 Million	+8.96%
2020-12-31	CN¥1.38 Billion ≈ $201.53 Million	-3.55%
2019-12-31	CN¥1.43 Billion ≈ $208.93 Million	-2.14%
2018-12-31	CN¥1.46 Billion ≈ $213.50 Million	+6.84%
2017-12-31	CN¥1.37 Billion ≈ $199.82 Million	+9.08%
2016-12-31	CN¥1.25 Billion ≈ $183.18 Million	+10.35%
2015-12-31	CN¥1.13 Billion ≈ $165.99 Million	-10.01%
2014-12-31	CN¥1.26 Billion ≈ $184.46 Million	+52.82%
2013-12-31	CN¥824.89 Million ≈ $120.71 Million	-13.34%
2012-12-31	CN¥951.88 Million ≈ $139.29 Million	+64.49%
2011-12-31	CN¥578.70 Million ≈ $84.68 Million	+9.69%
2010-12-31	CN¥527.56 Million ≈ $77.20 Million	+14.51%
2009-12-31	CN¥460.71 Million ≈ $67.42 Million	+16.51%
2008-12-31	CN¥395.43 Million ≈ $57.86 Million	-1.94%
2007-12-31	CN¥403.23 Million ≈ $59.01 Million	+1.99%
2006-12-31	CN¥395.35 Million ≈ $57.85 Million	+22.46%
2005-12-31	CN¥322.85 Million ≈ $47.24 Million	+29.68%
2004-12-31	CN¥248.95 Million ≈ $36.43 Million	-8.16%
2003-12-31	CN¥271.07 Million ≈ $39.67 Million	+29.33%
2002-12-31	CN¥209.59 Million ≈ $30.67 Million	-42.94%
2001-12-31	CN¥367.31 Million ≈ $53.75 Million	+50.29%
2000-12-31	CN¥244.41 Million ≈ $35.76 Million	-0.34%
1999-12-31	CN¥245.24 Million ≈ $35.89 Million	-4.46%
1998-12-31	CN¥256.69 Million ≈ $37.56 Million	-19.66%
1997-12-31	CN¥319.51 Million ≈ $46.75 Million	+76.50%
1996-12-31	CN¥181.03 Million ≈ $26.49 Million	-3.57%
1995-12-31	CN¥187.72 Million ≈ $27.47 Million	+70.80%
1994-12-31	CN¥109.91 Million ≈ $16.08 Million	+145.09%
1993-12-31	CN¥44.85 Million ≈ $6.56 Million	+24.05%
1992-12-31	CN¥36.15 Million ≈ $5.29 Million	--

About Vcanbio Cell & Gene Engineering Corp Ltd

SHG:600645 China Biotechnology

Market Cap

$1.20 Billion

CN¥8.21 Billion CNY

Market Cap Rank

#7853 Global

#1732 in China

Share Price

CN¥17.55

Change (1 day)

-1.74%

52-Week Range

CN¥16.74 - CN¥32.94

All Time High

CN¥68.93